Charles R. Kummeth - 07 Aug 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Brenda S. Furlow, Attorney-in-Fact
Issuer symbol
TECH
Transactions as of
07 Aug 2022
Transactions value $
-$4,425,984
Form type
4
Filing time
09 Aug 2022, 18:58:29
Previous filing
01 Aug 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +16.9K +7.2% $0.00 252K 07 Aug 2022 Direct F1
transaction TECH Common Stock Tax liability -$4.43M -11.6K -4.59% $382.97 240K 07 Aug 2022 Direct F1
holding TECH Common Stock 100 07 Aug 2022 By Step-Son
holding TECH Common Stock 100 07 Aug 2022 By Step-Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -16.9K -100% $0.00* 0 07 Aug 2022 Common Stock 16.9K Direct F3, F4
holding TECH Stock Options (Right to Buy) 256K 07 Aug 2022 Common Stock 256K $106.59 Direct F2
holding TECH Stock Options (Right to Buy) 195K 07 Aug 2022 Common Stock 195K $125.05 Direct F2
holding TECH Stock Options (Right to Buy) 90.3K 07 Aug 2022 Common Stock 90.3K $177.32 Direct F2
holding TECH Stock Options (Right to Buy) 60.2K 07 Aug 2022 Common Stock 60.2K $177.32 Direct F2
holding TECH Stock Options (Right to Buy) 85.7K 07 Aug 2022 Common Stock 85.7K $190.41 Direct F2
holding TECH Stock Options (Right to Buy) 57.2K 07 Aug 2022 Common Stock 57.2K $190.41 Direct F5
holding TECH Restricted Stock Units 12.9K 07 Aug 2022 Common Stock 12.9K Direct F3, F6
holding TECH Stock Options (Right to Buy) 57.4K 07 Aug 2022 Common Stock 57.4K $267.87 Direct F6
holding TECH Stock Options (Right to Buy) 38.3K 07 Aug 2022 Common Stock 38.3K $267.87 Direct F7
holding TECH Stock Options (Right to Buy) 16.7K 07 Aug 2022 Common Stock 16.7K $267.87 Direct F8
holding TECH Stock Options (Right to Buy) 16.7K 07 Aug 2022 Common Stock 16.7K $267.87 Direct F9
holding TECH Restricted Stock Units 8.02K 07 Aug 2022 Common Stock 8.02K Direct F3, F10
holding TECH Stock Options (Right to Buy) 31.3K 07 Aug 2022 Common Stock 31.3K $481.82 Direct F10
holding TECH Stock Options (Right to Buy) 20.9K 07 Aug 2022 Common Stock 20.9K $481.82 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 2,862 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 3,562 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on each of August 6, 2023 and August 6, 2024.
F2 Fully exercisable.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4 On 8/7/2022, the Board of Directors certified vesting of 16,937 performance RSUs.
F5 Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.
F6 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7 Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
F8 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F9 Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
F10 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11 Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.